Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore
10.1080/14737167.2023.2295474
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
Taylor & Francis
2024
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/247511 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-247511 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-2475112024-03-18T03:10:59Z Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore Elaine Hsuen Lim Andrew Lim Jasmeet Singh Khara John Cheong Jek Fong Sivabalan Sivanesan Matt Griffiths Emma New Soo-chin Lee MEDICINE 10.1080/14737167.2023.2295474 Expert Review of Pharmacoeconomics & Outcomes Research 24 3 413-426 2024-03-18T03:10:56Z 2024-03-18T03:10:56Z 2024-01-30 Article Elaine Hsuen Lim, Andrew Lim, Jasmeet Singh Khara, John Cheong, Jek Fong, Sivabalan Sivanesan, Matt Griffiths, Emma New, Soo-chin Lee (2024-01-30). Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore. Expert Review of Pharmacoeconomics & Outcomes Research 24 (3) : 413-426. ScholarBank@NUS Repository. https://doi.org/10.1080/14737167.2023.2295474 1473-7167 https://scholarbank.nus.edu.sg/handle/10635/247511 Taylor & Francis Taylor & Francis |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
description |
10.1080/14737167.2023.2295474 |
author2 |
MEDICINE |
author_facet |
MEDICINE Elaine Hsuen Lim Andrew Lim Jasmeet Singh Khara John Cheong Jek Fong Sivabalan Sivanesan Matt Griffiths Emma New Soo-chin Lee |
format |
Article |
author |
Elaine Hsuen Lim Andrew Lim Jasmeet Singh Khara John Cheong Jek Fong Sivabalan Sivanesan Matt Griffiths Emma New Soo-chin Lee |
spellingShingle |
Elaine Hsuen Lim Andrew Lim Jasmeet Singh Khara John Cheong Jek Fong Sivabalan Sivanesan Matt Griffiths Emma New Soo-chin Lee Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore |
author_sort |
Elaine Hsuen Lim |
title |
Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore |
title_short |
Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore |
title_full |
Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore |
title_fullStr |
Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore |
title_full_unstemmed |
Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore |
title_sort |
cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in singapore |
publisher |
Taylor & Francis |
publishDate |
2024 |
url |
https://scholarbank.nus.edu.sg/handle/10635/247511 |
_version_ |
1794549269168914432 |